NEW YORK (GenomeWeb) – Belgian MDx Firm Biocartis announced today that it has received a €1.4 million ($1.5 million) grant from the Flemish Agency for Innovation by Science and Technology (IWT) to support the development of liquid biopsy versions of its solid tumor BRAF and KRAS diagnostics for melanoma and colorectal cancer.

The funds, made as part of an IWT-subsidized collaboration project called Early Diagnosis by Easy Sampling, will also support more general research on improved liquid biopsy methodologies, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.